Pharmacokinetics of apatinib in healthy male Caucasian, Japanese and Chinese subjects.
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Breast cancer; Colorectal cancer; Fallopian tube cancer; Gastric cancer; Hepatocellular carcinoma; Non-small cell lung cancer; Ovarian cancer; Peritoneal cancer; Solid tumours
- Focus Pharmacokinetics
- 28 Sep 2017 New trial record
- 01 Sep 2017 Results assessing Pharmacokinetics of apatinib in healthy Caucasian, Japanese and Chinese subjects following a single-dose administration, were published in the Clinical Pharmacology in Drug Development Conference: 2017 Annual Meeting of the American College of Clinical Pharmacology.